Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21929)	6/6/1998 1:15:00 PM
From: WTDEC	Respond to of 32384

Henry, I have to agree this is very big news. My guess is that LGND and SBH research in the area is close to one year, if not more, ahead of what the article will report on. We know that LGND has been filing plenty of patents during this period. If they issue in as broad a form as some of us feel could be the case, we just might have a blocksmasher situation on our hands. Time will tell. Regards, Walter

To: Henry Niman who wrote (21929)	6/6/1998 2:19:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

<<The information that I could gather from someone familiar with the presentation was that the mimic was about 500 daltons> The three major classes of interferons(alfa,beta,gamma)that I am aware of have molecular weights ranging from 15,000 to 21,000 daltons. They each of course have overlapping, yet distinct biological activities. What activity are they looking for with one of 500 dalton weight?? Thanks, Greg